SCHEMBL20631121

SCHEMBL20631121

CC(=O)Nc1cn(O)c2c1CCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ HPGD P15428 1/20 0.37
▸ PARP14 Q460N5 1/20 0.36
▸ WDR5 P61964 1/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ GAA P10253 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ APP P05067 1/20 0.34
▸ BCHE P06276 1/20 0.34
▸ ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20631143 0.75 ALOX5 (0.36) ALDH1A1KDM4EHPGDKMT2A
SCHEMBL20631138 0.74 GRIA2 (0.35) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL9797400 0.71 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDPARP14MEN1
SCHEMBL23937907 0.70 ALOX5 (0.33) ALDH1A1KDM4EHPGDKMT2ANPC1
SCHEMBL20673851 0.70 TSHR (0.39) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL23937908 0.69 ALOX5 (0.35) KDM4E
SCHEMBL20631114 0.68 CNR2 (0.38) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20631141 0.68 FABP4 (0.39) KDM4EMEN1KMT2AGFER
SCHEMBL19995850 0.67 ALDH1A1 (0.44) ALDH1A1HPGDMAPTNPC1RAB9A
SCHEMBL20631117 0.67 MEN1 (0.35) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 — — EP disclosed
WO-2019010295-A1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LIMITED (KY) 2019-01-10 — — WO disclosed
Send feedback